The Urokinase Receptor Homolog Haldisin Is a Novel Differentiation Marker of Stratum Granulosum in Squamous Epithelia

Journal of Histochemistry and Cytochemistry

Volumn 61, Issue 11, 2013, Pages 802-813

  Gårdsvoll, Henrik ^a   Kriegbaum, Mette C ^a   Hertz, Emil P ^a   Alpízar Alpízar, Warner ^a,b   Ploug, Michael ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

C4.4A; differentiation marker; Haldisin; LU; Ly 6 uPAR protein domain family; LYPD5; PRO4356; squamous epithelium; stratum granulosum; uPAR

Indexed keywords

GLYCOLIPID; HALDISIN; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISULFIDE BOND; EPIDERMIS GRANULAR LAYER; EPIDERMIS STRATUM GERMINATIVUM; FEMALE; GLYCOSYLATION; HAIR FOLLICLE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN SECRETION; RAT; SKIN; SQUAMOUS EPITHELIUM; SWEAT GLAND;

C4.4A; DIFFERENTIATION MARKER; HALDISIN; LU; LY-6/UPAR PROTEIN DOMAIN FAMILY; LYPD5; PRO4356; SQUAMOUS EPITHELIUM; STRATUM GRANULOSUM; UPAR;

ANIMALS; CLONING, MOLECULAR; DROSOPHILA; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEOPLASMS, SQUAMOUS CELL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RECOMBINANT PROTEINS;

EID: 84887331252     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155413501879     Document Type: Article

References (32)

1. Davies BS,Beigneux AP,Barnes RH,Tu Y,Gin P,Weinstein MM,Nobumori C,Nyren R,Goldberg I,Olivecrona G, et al.GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.Cell Metab. 2010;12:42-52.
2. Favre B,Plantard L,Aeschbach L,Brakch N,Christen-Zaech S,de Viragh PA,Sergeant A,Huber M,Hohl D.SLURP1 is a late marker of epidermal differentiation and is absent in Mal de Meleda.J Invest Dermatol. 2007;127:301-308.
3. Fujihara Y,Tokuhiro K,Muro Y,Kondoh G,Araki Y,Ikawa M,Okabe M.Expression of TEX101, regulated by ACE, is essential for the production of fertile mouse spermatozoa.Proc Natl Acad Sci U S A. 2013;110:8111-8116.
4. Galat A.The three-fingered protein domain of the human genome.Cell Mol Life Sci. 2008;65:3481-3493.
5. Gårdsvoll H,Hansen LV,Jørgensen TJ,Ploug M.A new tagging system for production of recombinant proteins in Drosophila S2 cells using the third domain of the urokinase receptor.Protein Expr Purif. 2007;52:384-394.
6. Gårdsvoll H,Jacobsen B,Kriegbaum MC,Behrendt N,Engelholm L,Østergaard S,Ploug M.Conformational regulation of urokinase receptor function: impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia induction.J Biol Chem. 2011;286:33544-33556.
7. Gårdsvoll H,Kjaergaard M,Jacobsen B,Kriegbaum MC,Huang M,Ploug M.Mimicry of the regulatory role of urokinase in lamellipodia formation by introduction of a non-native interdomain disulfide bond in its receptor.J Biol Chem. 2011;286:43515-43526.
8. Gårdsvoll H,Werner F,Søndergaard L,Danø K,Ploug M.Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites.Protein Expr Purif. 2004;34:284-295.
9. Hansen LV,Gårdsvoll H,Nielsen BS,Lund LR,Danø K,Jensen ON,Ploug M.Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.Biochem J. 2004;380:845-857.
10. Hansen LV,Skov BG,Ploug M,Pappot H.Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.Lung Cancer. 2007;58:260-266.
11. Hinck AP.Structural studies of the TGF-betas and their receptors-insights into evolution of the TGF-beta superfamily.FEBS Lett. 2012;586:1860-1870.
12. Huai Q,Mazar AP,Kuo A,Parry GC,Shaw DE,Callahan J,Li Y,Yuan C,Bian C,Chen L, et al.Structure of human urokinase plasminogen activator in complex with its receptor.Science. 2006;311:656-659.
13. Jacobsen B,Muley T,Meister M,Dienemann H,Christensen IJ,Santoni-Rugiu E,Laerum OD,Ploug M.Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.J Thorac Oncol. 2013;8:152-160.
14. Jacobsen B,Santoni-Rugiu E,Illemann M,Kriegbaum MC,Laerum OD,Ploug M.Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma.Int J Cancer. 2012;130:2734-2739.
15. Kini RM,Doley R.Structure, function and evolution of three-finger toxins: mini proteins with multiple targets.Toxicon. 2010;56:855-867.
16. Kjaergaard M,Hansen LV,Jacobsen B,Gårdsvoll H,Ploug M.Structure and ligand interactions of the urokinase receptor (uPAR).Front Biosci. 2008;13:5441-5461.
17. Konishi K,Yamamoto H,Mimori K,Takemasa I,Mizushima T,Ikeda M,Sekimoto M,Matsuura N,Takao T,Doki Y, et al.Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer.Cancer Sci. 2010;101:2269-2277.
18. Korkmaz B,Kuhl A,Bayat B,Santoso S,Jenne DE.A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptors.J Biol Chem. 2008;283:35976-35982.
19. Kriegbaum MC,Jacobsen B,Hald A,Ploug M.Expression of C4.4A, a structural uPAR homolog, reflects squamous epithelial differentiation in the adult mouse and during embryogenesis.J Histochem Cytochem. 2011;59:188-201.
20. Kriegbaum MC,Persson M,Haldager L,Alpízar-Alpízar W,Jacobsen B,Gårdsvoll H,Kjaer A,Ploug M.Rational targeting of the urokinase receptor (uPAR): development of antagonists and non-invasive imaging probes.Curr Drug Targets. 2011;12:1711-1728.
21. Kurita A,Takizawa T,Takayama T,Totsukawa K,Matsubara S,Shibahara H,Orgebin-Crist MC,Sendo F,Shinkai Y,Araki Y.Identification, cloning, and initial characterization of a novel mouse testicular germ cell-specific antigen.Biol Reprod. 2001;64:935-945.
22. Lee PY,Wang JX,Parisini E,Dascher CC,Nigrovic PA.Ly6 family proteins in neutrophil biology.J Leukoc Biol. 2013;:.
23. Llinas P,Le Du MH,Gårdsvoll H,Danø K,Ploug M,Gilquin B,Stura EA,Menez A.Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.EMBO J. 2005;24:1655-1663.
24. Mertens HD,Kjaergaard M,Mysling S,Gårdsvoll H,Jørgensen TJ,Svergun DI,Ploug M.A flexible multidomain structure drives the function of the urokinase-type plasminogen activator receptor (uPAR).J Biol Chem. 2012;287:34304-34315.
25. Nevo Y,Ben-Zeev B,Tabib A,Straussberg R,Anikster Y,Shorer Z,Fattal-Valevski A,Ta-Shma A,Aharoni S,Rabie M, et al.CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy.Blood. 2013;121:129-135.
26. Nilton A,Oshima K,Zare F,Byri S,Nannmark U,Nyberg KG,Fehon RG,Uv AE.Crooked, coiled and crimpled are three Ly6-like proteins required for proper localization of septate junction components.Development. 2010;137:2427-2437.
27. Paret C,Hildebrand D,Weitz J,Kopp-Schneider A,Kuhn A,Beer A,Hautmann R,Zöller M.C4.4A as a candidate marker in the diagnosis of colorectal cancer.Br J Cancer. 2007;97:1146-1156.
28. Ploug M.Structure-driven design of radionuclide tracers for non-invasive imaging of uPAR and targeted radiotherapy. The tale of a synthetic peptide antagonist.Theranostics. 2013;3:467-476.
29. Ploug M,Ellis V.Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins.FEBS Lett. 1994;349:163-168.
30. Rasch MG,Lund IK,Illemann M,Høyer-Hansen G,Gårdsvoll H.Purification and characterization of recombinant full-length and protease domain of murine MMP-9 expressed in Drosophila S2 cells.Protein Expr Purif. 2010;72:87-94.
31. Syed MH,Krudewig A,Engelen D,Stork T,Klämbt C.The CD59 family member Leaky/Coiled is required for the establishment of the blood-brain barrier in Drosophila.J Neurosci. 2011;31:7876-7885.
32. Young SG,Zechner R.Biochemistry and pathophysiology of intravascular and intracellular lipolysis.Genes Dev. 2013;27:459-484.